Candel Therapeutics, Inc. - COM (CADL)

Historical Portfolio Holders from Q3 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
5.96M
Holdings value Q2 2024
$37M
Value change Q2 2024
+$14M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
45
Number of buys Q2 2024
39
Number of sells Q2 2024
-10
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 5.96M $37M +$14M $6.20 47
2024 Q1 3.78M $5.97M -$232K $1.58 18
2023 Q4 4.03M $5.92M -$1.2M $1.47 21
2023 Q3 5.26M $4.86M -$147K $0.92 19
2023 Q2 5.37M $6.77M -$143K $1.26 19
2023 Q1 5.48M $7.44M +$69.5K $1.35 20
2022 Q4 5.42M $9.7M -$1.79M $1.79 20
2022 Q3 6.08M $19.1M -$834K $3.14 22
2022 Q2 6.35M $20.6M -$1.16M $3.24 21
2022 Q1 6.67M $34M -$1.72M $5.08 21
2021 Q4 6.95M $54.4M +$876K $7.82 20
2021 Q3 4.88M $52.9M +$44.1M $10.84 12